| Mechanical properties, cytocompatibility and manufacturability of chitosan: PEGDA hybrid-gel scaffolds by stereolithography VB Morris, S Nimbalkar, M Younesi, P McClellan, O Akkus Annals of biomedical engineering 45, 286-296, 2017 | 199 | 2017 |
| Advances in stroke therapy H Jaffer, VB Morris, D Stewart, V Labhasetwar Drug delivery and translational research 1, 409-419, 2011 | 118 | 2011 |
| Big bottlenecks in cardiovascular tissue engineering NF Huang, V Serpooshan, VB Morris, N Sayed, G Pardon, OJ Abilez, ... Communications biology 1 (1), 199, 2018 | 82 | 2018 |
| Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector VB Morris, CP Sharma International journal of pharmaceutics 389 (1-2), 176-185, 2010 | 74 | 2010 |
| Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality VB Morris, CP Sharma Journal of colloid and interface science 348 (2), 360-368, 2010 | 69 | 2010 |
| Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain M Petro, H Jaffer, J Yang, S Kabu, VB Morris, V Labhasetwar Biomaterials 81, 169-180, 2016 | 67 | 2016 |
| Arginine-rich polyplexes for gene delivery to neuronal cells VB Morris, V Labhasetwar Biomaterials 60, 151-160, 2015 | 59 | 2015 |
| Studies on the condensation of depolymerized chitosans with DNA for preparing chitosan‐DNA nanoparticles for gene delivery applications VB Morris, S Neethu, TE Abraham, CKS Pillai, CP Sharma Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2009 | 48 | 2009 |
| Folic acid therapy in the fragile X syndrome WT Brown, EC Jenkins, E Friedman, J Brooks, IL Cohen, C Duncan, ... American Journal of Medical Genetics 17 (1), 289-297, 1984 | 48 | 1984 |
| Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes S Lu, VB Morris, V Labhasetwar Molecular pharmaceutics 12 (2), 621-629, 2015 | 41 | 2015 |
| Enhanced in-vitro transfection and biocompatibility of L-arginine modified oligo (-alkylaminosiloxanes)-graft-polyethylenimine VB Morris, CP Sharma Biomaterials 31 (33), 8759-8769, 2010 | 41 | 2010 |
| Stability and catalytic properties of encapsulated subtilisin in xerogels of alkoxisilanes K Sangeetha, VB Morris, TE Abraham Applied Catalysis A: General 341 (1-2), 168-173, 2008 | 33 | 2008 |
| Folate mediated l-arginine modified oligo (alkylaminosiloxane) graft poly (ethyleneimine) for tumor targeted gene delivery VB Morris, CP Sharma Biomaterials 32 (11), 3030-3041, 2011 | 31 | 2011 |
| Effectiveness of small interfering RNA delivery via arginine-rich polyethylenimine-based polyplex in metastatic and doxorubicin-resistant breast cancer cells S Lu, VB Morris, V Labhasetwar Journal of Pharmacology and Experimental Therapeutics 370 (3), 902-910, 2019 | 21 | 2019 |
| Superoxide dismutase-loaded biodegradable nanoparticles targeted with a follicle-stimulating hormone peptide protect Sertoli cells from oxidative stress DC Snow-Lisy, ES Sabanegh Jr, MK Samplaski, VB Morris, ... Fertility and sterility 101 (2), 560-567. e3, 2014 | 17 | 2014 |
| Folic acid‐conjugated depolymerized quaternized chitosan as potential targeted gene delivery vector VB Morris, CKS Pillai, CP Sharma Polymer international 60 (7), 1097-1106, 2011 | 14 | 2011 |
| Synthesis and characterization of novel water-soluble polyamide based on spermine and aspartic acid as a potential gene delivery vehicle BM Viola, TE Abraham, DS Arathi, E Sreekumar, MR Pillai, TJ Thomas, ... eXPRESS Polymer Letters 2 (5), 330-338, 2008 | 10 | 2008 |
| Effectiveness of siRNA delivery via arginine-rich PEI-based polyplex in metastatic and doxorubicin resistant breast cancer cells S Lu, VB Morris, V Labhasetwar Journal of Pharmacology and Experimental Therapeutics, 2019 | 8 | 2019 |
| Chitosan: PEGDA hybrid-gel scaffolds printed by stereolithography N Siddharth, M Viola, Y Mousa, A Ozan Frontiers in Bioengineering & Biotechnology 4, 2016 | 4 | 2016 |
| Drug Delivery Transl H Jaffer, VB Morris, D Stewart, V Labhasetwar Res 1, 409-419, 2011 | 4 | 2011 |
Vinod Labhasetwar, Ph.D.Professor, Biomedical Engineering, Lerner Research Institute, Cleveland ClinicVerified email at ccf.org
